AzTrials
AzTrials

Self AdministrationAUTOGESTMEDNCT06639113

From Administration of Oral Medicines by Nurses to Controlled Self-administration: Impact on Safety of Administration During Hospitalisation

A study testing Self-administration medicines in people with Self Administration, run by Centre Hospitalier de Valenciennes at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Medication administration practices during patient hospital stay tend to improve patient autonomy. Several studies have concluded that self-administration of medication programs in hospital centers have a beneficial effect on patients' knowledge of their medications, their compliance and the safety of administration. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Self Administration
What is being tested?
Self-administration medicines
Could I receive a placebo?
No, everyone receives an active treatment
How many people
192 participants
Where
1 siteFrance
Study dates
24 May 2024to Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Care in the rehabilitation unit of Hospital in Valenciennes, France
  • Patient with a planned stay of 7 days or more
  • Patient on chronic treatment before admission to hospital ;
  • Patients taking their treatment alone at home;

Who cannot join

  • Age < 18 years old
  • Patients with poor compliance
  • No chronic treatment
  • Unstable disease
  • Major cognitive, memory or depressive disorders
  • Swallowing disorders
Show all 10Show fewer
  • Prehension problems
  • Patient under legal protection
  • Patient under guardianship or curatorship
  • Patient included in another trial

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • CH Valenciennes

    Valenciennes, 59300

    Hanane FODIL, 0327140665, fodil-h@ch-valenciennes.fr

    Quentin HIVER

    Recruiting

Other trials in France

About this study

Official title: Evaluation of the Safety of a Change of Practice in the Administration of Oral Medication During Hospitalisation: From Administration by the Nurse to Supervision of Self-administration of Medication in the Locomotor and Polyvalent Rehabilitation Department of the Valenciennes Hospital Centre.

Medication administration practices during patient hospital stay tend to improve patient autonomy. Several studies have concluded that self-administration of medication programs in hospital centers have a beneficial effect on patients' knowledge of their medications, their compliance and the safety of administration. Nevertheless, few studies have been carried out in France on this subject. The aim of this study is to evaluate the impact of the change of nurses administration practices from the administration of each drugs to supervision of self-administration by the patient under a self-administration program.

Being tested
Self-administration medicines
Keywords
Rehabilitation, Self-management of medication, Administration, Autonomy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Self-administration medicinesBehavioural

    Management of drugs' administration by the patient

Study groups in NCT06639113
Study groupRoleWhat they receive
Self administration of medication by the patientExperimentalSelf administration of medication by the patient
Receives: Behavioral: Self-administration medicines
Administration of medication by the nursesNo interventionAdministration of medication by the nurses during medication administration rounds

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total number of oral medication administration errors in self-administered patients

    Total number of oral medication administration errors in self-administered patients

    Measured: After 7 days of self-administration

  2. Total number of oral medication administration errors in patients receiving administration by nurses

    Total number of oral medication administration errors in patients receiving administration by nurses

    Measured: After 7 days of administration by nurses

Secondary outcomes (4)
  1. Medication compliance in self-managed patients

    Medication compliance is assessed using the questionnaire "Evaluation of medication compliance" provided by the French health insurance system.

    This questionnaire consists of 6 questions with "yes" or "no" answers. Each "no" answer is worth 1 point, each "yes" answer is worth 0 points. A patient with poor medication compliance will have a score of 3 or less.

    Measured: At the beginning of the study

  2. Medication compliance in self-managed patients

    Medication compliance is assessed using the questionnaire "Evaluation of medication compliance" provided by the French health insurance system.

    This questionnaire consists of 6 questions with "yes" or "no" answers. Each "no" answer is worth 1 point, each "yes" answer is worth 0 points. A patient with poor medication compliance will have a score of 3 or less.

    Measured: 15 days after hospital discharge for self-managed patients

  3. Patient satisfaction with self-administration of oral medication

    Patient satisfaction was assessed using a questionnaire designed by the investigator, consisting of 9 questions giving a total of 45 points.

    The higher the total, the higher the level of satisfaction.

    Measured: Within 24 hours of discharge from hospital

  4. Care staff satisfaction with self-administration

    Care staff satisfaction was assessed using a questionnaire designed by the investigator, consisting of 4 questions totalling 20 points.

    The higher the total, the higher the level of satisfaction.

    Measured: 6 months after the beginning of the study

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Oct 2024
  2. Study start24 May 2024
  3. Primary completionMay 2027 (estimated)
  4. Study completionJun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
192 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06639113
Sponsor's protocol ID
2023-02-04
Acronym
AUTOGESTMED
Status last verified
Oct 2026
First submitted
5 Sep 2024
Last updated
20 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Self-administration medicines in people with Self Administration, run by Centre Hospitalier de Valenciennes at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 20 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Quentin HIVER (0327143333, hiver-q@ch-valenciennes.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total number of oral medication administration errors in self-administered patients (time frame: After 7 days of self-administration). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in